The neurobiological heterogeneity of schizophrenia is widely accepted, but it is unclear how mechanistic differences converge to produce the observed phenotype. Establishing a pathophysiological model that accounts for both heterogeneity and phenotypic similarity is essential to inform stratified treatment approaches. In this cross-sectional diffusion tensor imaging (DTI) study, we recruited 77 healthy controls (HC), and 71 patients with DSM-IV diagnosis of schizophrenia (SCZ), and reconstructed the structural connectivity of 90 brain regions covering entire cerebral cortex. We first confirmed the heterogeneity in structural connectivity by showing a reduced inter-individual similarity in SCZ compared with HC. Moreover, we found it was not possible to cluster patients into subgroups with shared patterns of dysconnectivity, indicating a high degree of mechanistic divergence in schizophrenia.
INTRODUCTION
Schizophrenia is often considered as an illness where aberration in brain connectivity is a core pathophysiological mechanism. Since Buchsbaum et al.'s initial diffusion imaging study in patients with schizophrenia 1 , several reports implicating abnormal white matter integrity in schizophrenia have been published [2] [3] [4] [5] .
Nevertheless, the spatial localisations of white matter (WM) abnormalities have been diffuse 3, 4, 6 (including corpus callosum, cingulate bundle, and uncinate fasciculus, fibres from superior frontal gyrus, superior temporal gyrus, thalamus, the internal capsule, cerebellum, hippocampus, the parietal lobe, and the occipital lobe), with tracts serving richly connected hub regions being disproportionately affected 7 .
Studies involving very large sample of patients indicate that regional abnormalities are indeed present, but they are of moderate magnitude even in the most affected tracts (Cohen's d< 0.42) 6 . This lack of consistency has often been ascribed to neurobiological heterogeneity of schizophrenia where region-specific pathology results in distinct sub-groups of patients 3, 8 . While the inter-individual variations in the severity of symptom dimensions and cognitive ability appears to be linked to differential WM integrity [9] [10] [11] [12] , it is important to note that most studies to date have linked distributed WM deficits to the broad clinical phenotype of schizophrenia, rather than hitherto unknown neurobiological subgroups. If aberrant brain connectivity is indeed a neurobiological substrate of the schizophrenia phenotype, then it is likely that these spatially distinct WM changes converge to deviate certain emergent features of WM architecture. In other words, we can expect to see a large effect-size deficit in WM architecture despite a low degree of inter-individual similarity in spatial distribution of WM abnormalities in schizophrenia.
With respect to the topography of WM tracts, direct structural connectivity among brain regions appears to be generally sparse, with connection density being as low as 3.0% when measured using highly resolved diffusion imaging 13 . Thus, in a healthy brain, a given region connects well to some regions, that might be functionally relevant, while connects sparsely to those that are not as relevant. Such intra-individual spatial variation in the connectivity of one brain region to the rest forms the basis of distributed brain networks with physiological specificity 14 .
Interestingly, tracer studies in monkeys indicate that the diverse connectional topographies of individual brain regions show remarkable inter-individual similarity 15, 16 . These observations suggest that 'topographic diversity in structural connectivity' is likely to be an important feature underpinning domain-specific neural functions. In this paper, we use the term topographic diversity to refer to within-individual variability across space, and contrast this from within-individual variability across time (e.g. training effects 17 ).
In this study, we first test if the inter-individual similarity in regional WM connectivity is reduced in a group of 71 patients with schizophrenia and 77 matched healthy controls. Second, using WM pathways that are relevant to variations in symptom severity among patients, we test whether the heterogeneity of WM connectivity in patients can be understood by a number of subgroups. Third, we test whether topographic diversity in patients deviates sufficiently (i.e. effect size of 1 or greater) contributing to statistical discrimination of schizophrenia phenotype from healthy controls. We also tested whether the disrupted WM architecture emerged from aberrations in strong, rather than weakly connected WM pathways. Our overall aim was to establish a quantifiable convergent mechanism that is proximal to the syndromic expression of schizophrenia with an effect size that is comparable to that reported for observable cognitive deficits in this illness. There is an active pursuit to alter WM structure (especially myelin content) as a means to impact cognitive deficits in schizophrenia. To this end, identifying a potential physiological end-point that is not only proximal to disease expression but also relevant to substantial number, if not all, patients with schizophrenia is a critical step to make further progress.
METHODS

Subjects and Image Acquisition
In the current sample ( 
Image Preprocessing and Construction of Connectivity Matrix
Brain was extracted from all images using FSL's brain extraction tool 18, 19 . The diffusion-weighted volumes were corrected for eddy-current induced distortions and movements by affine registration to the no diffusion-weighted (B0) image using the diffusion-specific FSL's EDDY tool 20 .
Fiber-tracking was performed by the MRtrix0. If a common pathological process resulted in the reduced variance (diversity), a consistent spatial distribution of changes in FA can be expected. We estimated the between-subject similarity by calculating the correlations of the whole brain connectivity (i.e., the FA-weighted structural connectivity matrix ) between subjects of the same group. This resulted in a similarity matrix for each group. This similarity distribution was then compared between healthy subjects and patients with schizophrenia by t-test to examine whether the similarity was significantly different in group level.
Clustering Patients with Schizophrenia
Followed the approach of detecting subgroups in patients 25 , we tried to identify these subgroups, if any, by applying two different clustering methods to the connectivity pattern, i.e., the FA weighted structural connectivity between brain regions.
K-means clustering:
We applied k-means clustering to the patients and controls, separately. The number of clusters ( value) in our analysis ranged from 1 to 6. The optimal number of clusters was determined by the GAP statistics 26 , measuring the quality of the resulting clusters.
CCA-based hierarchical clustering:
To avoid the possibility that the clustering result was affected by the inherent limitations of k-means, we also employed another clustering method which had been successfully applied recently to define neurophysiological subtypes of depression 27 . The structural connectivity was first selected according to their (Spearman's rank) correlations with the PANSS scales (Positive scale, or Negative scale, or General Psychopathology scale with < 0.005, uncorrected) in patients. Secondly, by canonical correlation analysis (CCA), we identified two linear combinations of those symptom-associated structural connectivity, which had the most significant symptom-associations ( > 0.9). We applied a hierarchical clustering to identify subgroups of patients to these two linear-combined symptom-associated canonical components. As these features are selected for their relevance to symptom severity, we expected to see a few subgroups within the patient sample, but no subgroups when applied to healthy controls.
The Topographic Diversity of Structural Connectivity
We computed the variance of the brain structural connectivity for each subject as follows: connections range from 5 to 25 were also calculated and we found the effects were similar.
Classification of Patients and Controls
To study if the topographic diversity provided any incremental value in distinguishing patients from healthy controls, we used a random forest classification Firstly, we ran the random forest algorithm with 1000 trees for 100 times on the predictors to obtain an average importance score for each predictor. The highest few predictors were used in the final model to classify the subjects into patients and controls. Secondly, using five-fold cross-validation with 100 repeats, we compared the classification accuracies of these two models by a paired-sample t-test， and also estimated an average accuracy of classification for each model. The results were validated by exploring different numbers of selected predictors for these models.
RESULTS
Inter-individual similarity of structural connectivity decreased in patients
Healthy controls had greater overall similarity in structural connectivity ( = 2.76 × 10 −74 , = 18.52, ℎ ′ = 0.51), indicating notable within-group heterogeneity in structural connectivity patterns among patients ( figure 1A ).
Topographic diversity of structural connectivity reduced in patients
Compared with patients, HC had greater diversity (variance) in the whole brain Furthermore, we found for 61 out of 62 brain regions identified above, the connectivity strength reduced in the top 10 strongest connections ( < 0.05 FDR corrected) (figure1D, table s2), but no significant changes in the lowest 10 weak connections ( figure 1D, table s2 ).
Clusters based on WM connectivity patterns
According to the quality of clusters given by the GAP statistic 26 , we found that the optimal number of clusters given by k-means clustering was 1 in both patients and controls ( figure 2A) . Similarly, the CCA-based hierarchical clustering algorithm gave no evidence for any subgroup in patients (figure 2B, tables s3 and s4).
Topographic diversity discriminates patients from controls
Six connections, predominantly frontal (table 2) , were selected by the random forest and the final model with these variables yielded a mean accuracy rate of 76.1%
(sensitivity 73.3%, specificity 78.6%). Introducing the topographic diversity to the model, i.e. the variance and mean FA of top 10 connections from each region, the mean accuracy rate increased to 79.6% (sensitivity 78.3%, specificity 81.3%), which was significantly better than the model based on structural connectivity alone ( = 4.29 × 10 −24 by a paired-sample t-test 29 , figure 3A ), and such improvement was not affected by the number of predictors selected (figure 3B). No correlation (table s5) has been identified between either the regionally or the globally diversity and the medical treatment (the CPZ dosage in table s1).
DISCUSSION
To our knowledge, this is the first study to systematically examine if the individually distinct WM changes seen in patients with schizophrenia lead to a convergent effect that is relevant to the expressed clinical phenotype. We report 4
major findings from the current study. 1) The inter-individual spatial similarity in WM connectivity is greatly reduced in schizophrenia compared to healthy controls. 2)
Despite the spatial dissimilarity, patients with schizophrenia, as a group, show large effect-sized reductions in topographic diversity, which when used in conjunction with the observed pattern of regional changes in each patient, results in successful discrimination of the patients from controls.
3) The reduced topographic diversity relates almost exclusively to disruptions in strongly connected WM pathways. 4) We could not identify subgroups of patients with clustering of WM connectivity patterns.
Our findings add an important clarification to the divergent results of DTI studies in schizophrenia. In patients with schizophrenia, subtle disruptions in WM connectivity occur in a person-specific (idiosyncratic) fashion. The patterns of resulting deficits, when combined, are sufficiently discriminative of the phenotype, but this is not due to a generalised non-specific deficit affecting all WM pathways.
Our results suggest that the WM deficit in schizophrenia is likely to be specific to the strongly connected pathways that are more liable to have direct axonal connections.
This inference reconciles the spatial divergence 30 with the discriminatory accuracy 31-34 (generally 70-90%) when using multivariate approaches in the DTI studies.
We lacked neuropsychological data to examine cognitive specificity of regional There is an enthusiastic acceptance that schizophrenia is a neurobiologically heterogeneous illness; but the evidence demonstrating such heterogeneity is not yet available, or at best, weak 37 . In most studies, the absence of clear demarcation of a neurobiological feature between patients and controls (i.e. small effect size) or the demonstration of increased variance 38 among patients is taken to be supportive of the underlying heterogeneity. While this is certainly a viable explanation, we report that convergent neurobiological abnormalities at a systemic level can stem from diverse changes. Thus, the neurobiological heterogeneity inferred at a lower level, may not be observable at the 'systems' level. It is important to note that the lack of clustering solutions does not negate the neurobiological heterogeneity of schizophrenia. On the contrary, these results are expected if there is a very high level of heterogeneity. But the large effect-size reduction in systems-level property (diversity), reminds us that it may be premature to dismiss the possibility that schizophrenia, as observed by contemporary clinicians, could be a system-level deficit in WM architecture that may vary only in degree across individuals (figure s1 summarizes the possible mechanistic nature of schizophrenia).
In summary, the convergence of highly individualized (idiosyncratic) pattern of structural dysconnectivity resulting in reduced topographic diversity in schizophrenia validates the century-old concept of dysconnectivity or integration deficit as a binding feature that brings together seemingly disparate dimensions of symptoms in patients with schizophrenia. When parsing the heterogeneity of psychosis, it is critical to accommodate emergent system-level properties that can capture the gestalt of the currently used clinical construct of schizophrenia.
Limitation
It is important to consider 2 important caveats in this study. We recruited a sample of medicated patients with an established history of schizophrenia. While this reduced the heterogeneity that is typically seen in early stage, drug-naï ve samples with relatively weaker diagnostic stability, a selection-bias towards a single group of patients with relatively more severe illness and poor prognosis cannot be excluded. It is rather surprising that this bias has not improved the inter-individual similarity in WM aberrations. Secondly, compared to recent consortium-based neuroimaging studies 6 , our sample size was relatively modest. This might explain the lack of clustering solutions within the patient group. Nevertheless, it is acknowledged that the heterogeneity in psychiatric disorders are expected to be diffuse 39 ; as a result, an 'optimal' clustering solution may not be achieved even in large samples 40 . Negative scale 9.9 ± 2.6
General Psychopathology scale 22.1 ± 3.5 Table 2 . Selected predictors in two different random forest models. 
